⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL29828683 | 0.97 | — | — | |
| SCHEMBL4875489 | 0.71 | — | — | |
| SCHEMBL3686601 | 0.65 | — | — | |
| SCHEMBL22237561 | 0.65 | — | — | |
| SCHEMBL993545 | 0.61 | — | — | |
| SCHEMBL7277052 | 0.59 | — | — | |
| SCHEMBL72400 | 0.58 | — | — | |
| SCHEMBL2139113 | 0.57 | — | — | |
| SCHEMBL3870589 | 0.56 | — | — | |
| SCHEMBL1199564 | 0.56 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119604494-A | PCSK9 inhibitors and methods of use thereof | 阿斯利康(瑞典)有限公司 | 2025-03-11 | — | — | CN | claimed |
| CN-117729916-A | Benzodioxane modulators of leukotriene A4 hydrolase (LTA 4H) for the prevention and treatment of aging-related diseases | 万能溶剂有限公司 | 2024-03-19 | — | — | CN | claimed |
| CN-115151534-B | Inhibitors of interleukin-1 receptor associated kinase (IRAK)/FMS-like receptor tyrosine kinase (FLT 3), pharmaceutical products thereof and methods of use thereof | 南京药石科技股份有限公司 | 2024-02-06 | — | — | CN | claimed |
| CN-115315424-A | 2-methyl-aza-quinazolines | 拜耳公司 | 2022-11-08 | — | — | CN | claimed |
| CN-115151534-A | Inhibitors of interleukin-1 receptor-related kinase (IRAK)/FMS-like receptor tyrosine kinase (FLT 3), pharmaceutical products thereof, and methods thereof | 南京药石科技股份有限公司 | 2022-10-04 | — | — | CN | claimed |
| WO-2021159993-A1 | INHIBITORS OF INTERLEUKIN-1 RECEPTOR ASSOCIATED KINASE (IRAK) /FMS-LIKE RECEPTOR TYROSINE KINASE (FLT3), PHARMACEUTICAL PRODUCTS THEREOF, AND METHODS THEREOF | PHARMABLOCK SCIENCES (NANJING) , INC. (CN) | 2021-08-19 | — | — | WO | claimed |
| WO-2020071550-A1 | CDK8 INHIBITOR AND USE OF SAME | 京都薬品工業株式会社 | 2020-04-09 | — | — | WO | claimed |
| CN-105968054-A | Preparation of pimobendan key intermediate | 海门慧聚药业有限公司 | 2016-09-28 | — | — | CN | claimed |
| CN-105555786-A | Substituted dihydropyrido [3,4-b ] pyrazinones as dual inhibitors of BET proteins and polo-like kinases | Bayer Pharma AG | 2016-05-04 | — | — | CN | claimed |
| CN-103991942-B | The treatment process of chlorophenols Micropollutants in a kind of water body | UNIVERSITY OF SCIENCE AND TECHNOLOGY OF SUZHOU (CN) | 2015-12-30 | — | — | CN | claimed |
| WO-2015193229-A1 | BET-PROTEIN INHIBITING 1,4-DIHYDROPYRIDO[3,4-B]PYRAZINONES WITH META-SUBSTITUTED AROMATIC AMINO- OR ETHER GROUPS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2015-12-23 | — | — | WO | claimed |
| CN-104987310-A | Synthesis process of levosimendan | UNIV QINGDAO AGRICULTURAL | 2015-10-21 | — | — | CN | claimed |
| CN-102341394-B | Poly (ADP-Ribose) Polymerase (PARP) Inhibitors | TAKEDA PHARMACEUTICAL | 2015-04-15 | — | — | CN | claimed |
| EP-0920429-A1 | SUBSTITUTED PYRIDO- OR PYRIMIDO-CONTAINING 6,6- OR 6,7-BICYCLIC DERIVATIVES | PFIZER INC. (US) | 1999-06-09 | — | — | EP | claimed |
| WO-1998005661-A1 | SUBSTITUTED PYRIDO- OR PYRIMIDO-CONTAINING 6,6- OR 6,7-BICYCLIC DERIVATIVES | PFIZER INC. (US) | 1998-02-12 | — | — | WO | claimed |
| EP-0814808-A1 | PHARMACEUTICAL, COSMETIC AND/OR FOOD COMPOSITION HAVING ANTI-OXIDANT PROPERTIES | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 1998-01-07 | — | — | EP | claimed |
| WO-1996028160-A1 | PHARMACEUTICAL, COSMETIC AND/OR FOOD COMPOSITION HAVING ANTI-OXIDANT PROPERTIES | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 1996-09-19 | — | — | WO | claimed |
| WO-1995029255-A1 | LUMINESCENCE-BASED DIAGNOSTICS | MEDILITE DIAGNOSTIKA (US) | 1995-11-02 | — | — | WO | claimed |
| CN-122070282-A | Pyrazole-1-carboxamides as RIP1 kinase inhibitors | 比西切姆有限公司 | 2026-05-19 | — | — | CN | disclosed |
| WO-1995029255-A1 | LUMINESCENCE-BASED DIAGNOSTICS | MEDILITE DIAGNOSTIKA (US) | 1995-11-02 | — | — | WO | disclosed |